ADIPOQ and type 2 diabetes mellitus: The FGF21 variant LY2405319 has been tested in patients with obesity and type 2 diabetes, with beneficial effects on lipid metabolism, body weight, fasting insulin and adiponectin levels, but no significant reduction in fasting glucose levels [228].